Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.

  2022 2021 2020 2019 2018

Year wise published articles

30 30 13 4 7

Year wise citations received

59 69 60 48 62
Journal total citations count 548
Journal Impact Factor 2.31
Journal 5 years Impact Factor 3.74
Journal CiteScore 4.86
Journal h-index 12
Important citations

Conjugar a farmacogenética ea monitorização terapêutica de fármacos: uma estratégia na otimização e individualização da farmacoterapia

Pharmacogenetics Informed Decision Making in Adolescent Psychiatric Treatment: A Clinical

ESTABLISHING THE ROADMAP FOR THE IMPLEMENTATION OF GENOMIC MEDICINE AND PHARMACOGENOMICS IN THE UNITED ARAB EMIRATES

Pharmaceutical applications based on next generation sequencing technology in oncologic drug development

Diabetes Mellitus: Classification, Symptoms and Management: A Review

Pharmacogenomics and Phytochemicals

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes

Pharmacogenomic Advancements For The Management Of Diabetes Mellitus

Personalized medicine: A step forward in dental treatment

Farmakogenetinio tyrimo vertinimas psichiatrijoje: retrospektyvi klinikini? atvej? analiz?

Knowledge, Attitudes, and Perceived Barriers toward Genetic Testing and Pharmacogenomics among Healthcare Workers in the United Arab Emirates: A Cross-Sectional Study

The Pharmaceutical Applications of Next Generation Sequencing in Oncology Drug Designing and Development

Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report

Association between Paraoxonase-1 p. Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population

Clinical relevant polymorphisms affecting clopidogrel pharmacokinetics and pharmacodynamics: Insights from the Puerto Rico Newborn Screening Program

Cardiovascular pharmacogenetics of antihypertensive and lipid-lowering therapies

Effects of CYP2C19 Variants on Fluoxetine Metabolism in vitro

Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population

Pharmacogenetic research activity in Central America and the Caribbean: a systematic review

Dextromethorphan addiction mediated through the NMDA system: common pathways with alcohol?